A randomized trial to assess the cardiovascular mortality of sevelamer versus calcium carbonate (TUMS) in incident hemodialysis patients.


Estimated Time to View: 20 minutes
Title: Sevelamer versus TUMS in Incident Hemodialysis Patients
Author: Ananda Gurram, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2013, Volume 4, Number 19
Disclaimers: None
Resource Type: Twitter Transcript
Recommend to a Colleague/Friend: Roll Over
Review this teaching resource: Click here

Pin this resource



Read transcript

Transparent Peer Review

GD Star Rating

To learn more about our 6-point transparent peer review system, click here



More in End-Stage Renal Disease, Hemodialysis, Renal Replacement (2 of 61 articles)